Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Oryzon Genomics (ORY SM)
Watchlist
54
Analysis
Health Care
•
Spain
Oryzon Genomics, SA is a clinical stage biopharmaceutical company that develops epigenetics-based therapeutics.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Oryzon Genomics
•
15 Jun 2020 16:50
•
Issuer-paid
Oryzon Genomics - Third positive update from Phase II ALICE trial
Last Friday, Oryzon presented an updated set of data from the Phase IIa ALICE trial in acute myeloid leukaemia (AML) at the virtual 25th Congress...
Edison Investment Research
Follow
114 Views
Share
bullish
•
Oryzon Genomics
•
14 Apr 2020 18:14
•
Issuer-paid
Oryzon Genomics - More data support vafidemstat for aggression
On 3 April 2020, Oryzon reported interim data for the first time from its two Phase IIa trials REIMAGINE-AD and ETHERAL. Both explore the company’s...
Edison Investment Research
Follow
304 Views
Share
bullish
•
Oryzon Genomics
•
20 Jan 2020 17:24
•
Issuer-paid
Oryzon Genomics - More to come after a year of data readouts
As we expected, 2019 was a year of data readouts for epigenetics specialist Oryzon. The company presented new data from the ongoing Phase IIa...
Edison Investment Research
Follow
782 Views
Share
bullish
•
Oryzon Genomics
•
10 Dec 2019 18:32
•
Issuer-paid
Oryzon Genomics - Maturing ALICE trial dataset continues to impress
On 9 December 2019, Oryzon presented more data from the Phase II ALICE trial at the 61st ASH annual meeting in Orlando, Florida. The single-arm,...
Edison Investment Research
Follow
1.7k Views
Share
bullish
•
Oryzon Genomics
•
30 Sep 2019 21:58
•
Issuer-paid
Oryzon Genomics - Interim Phase II CLEPSIDRA results at ESMO
On 28 September 2019, Oryzon presented additional data from its Phase IIa CLEPSIDRA trial with iadademstat, a selective LSD1 inhibitor, at the ESMO...
Edison Investment Research
Follow
844 Views
Share
First
Previous
6
7
8
9
10
11
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x